Cargando…
Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China
The direct-acting antiviral agents (DAAs) have drastically improved the prognosis of hepatitis C virus (HCV) patients. However, the resistance-associated variants (RAVs) to DAAs may hamper treatment. There was a lack of data on the prevalence of pre-exist RAVs in Chinese HCV-infected patients. We pe...
Autores principales: | Li, Zhanyi, Zhang, Ying, Liu, Ying, Shao, Xiaoqiong, Luo, QiuMin, Cai, Qingxian, Zhao, Zhixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428597/ https://www.ncbi.nlm.nih.gov/pubmed/28489763 http://dx.doi.org/10.1097/MD.0000000000006830 |
Ejemplares similares
-
Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
por: Li, Zhanyi, et al.
Publicado: (2017) -
Effectiveness of direct-acting antivirals for hepatitis C virus infection in hepatitis C/HIV coinfected individuals: A multicenter study
por: Machado, Soraia M., et al.
Publicado: (2020) -
Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
por: Mohamed Abdelnajid, Doaa, et al.
Publicado: (2023) -
Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders
por: Mert, Duygu, et al.
Publicado: (2020) -
Hepatitis C virus genotype and subtype distribution among ethnic minorities in Liaoning Province of China
por: Li, Rongkuan, et al.
Publicado: (2021)